title: Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugs.
abstract: The purpose of this study was to clarify whether 5-fluoro-2'-deoxyuridine (FdUrd) is superior to 5-fluorouracil (5-FU) as an effector in the radiation-activated prodrugs which we have been developing. The in vitro cytotoxicity of 5-FU and FdUrd was compared in two murine tumor and four human pancreatic cancer cell lines using a colony assay and in vivo efficacy was compared with SCCVII tumor using a growth delay time assay. FdUrd was slightly more hydrophilic than 5-FU. In vitro, FdUrd was more efficient than 5-FU in two lines, whereas 5-FU was more efficient in two lines and the two drugs were almost equal in efficacy in the remaining two. The concentration to reduce tumor cell survival to 50% after 24-h drug exposure was 5-32 microM for both 5-FU and FdUrd in murine lines, while it was 30-210 microM in human pancreatic cancer cell lines. The difference in relative efficacy of the two drugs among these cell lines could not be attributed to the rate of intracellular uptake of the compounds. FdUrd was less toxic than 5-FU in C3H/He mice, and FdUrd was less efficient than 5-FU in SCCVII tumors in vivo. These results suggest that FdUrd is not necessarily more potent than 5-FU, and development of the FdUrd prodrugs may not necessarily turn out to be fruitful.
authors.affiliation: Department of Radiology, Nagoya City University Medical School, Japan. yshiba@med.nagoya-cu.ac.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Shibamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Mimasu
authors.forename: Y
authors.initials: Y
authors.lastname: Tachi
authors.forename: H
authors.initials: H
authors.lastname: Hatta
authors.forename: S
authors.initials: S
authors.lastname: Nishimoto
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D003114:Colony-Forming Units Assay; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D051379:Mice; D008809:Mice, Inbred C3H; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011355:Prodrugs / Q000528:radiation effects*; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D005467:Floxuridine; D005472:Fluorouracil